Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cyclin and CBS domain divalent metal cation transport mediator 4 (CNNM4) is a magnesium transporter predominantly expressed in the basolateral membranes of epithelial cells in the intestine and ameloblasts in teeth. It mediates the extrusion of intracellular Mg2+ in exchange for extracellular Na+, playing a central role in systemic magnesium balance and proper enamel formation. CNNM4 includes several structural domains: a transmembrane DUF21 domain, a pair of CBS (cystathionine β-synthase) regulatory domains, and a cyclic nucleotide-binding homology (CNBH) domain, all involved in Mg2+-ATP binding, protein-protein interactions, and cellular localization. Germline mutations of *CNNM4* cause Jalili syndrome—a rare autosomal recessive disorder combining amelogenesis imperfecta and retinal cone-rod dystrophy due to defective magnesium transport in dental and retinal tissues. CNNM4 may also regulate energy metabolism and is inversely linked to tumor progression in some cancer types[1][2][3][5][6]. There are currently no drugs established to directly target CNNM4.
Not established for any marketed or investigational drugs; CNNM4 primarily mediates Na+/Mg2+ exchange and is indirectly implicated in magnesium homeostasis and possibly tumor biology through energy metabolism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclin and CBS domain divalent metal cation transport mediator 4 (CNNM4).